¶ Qu Biologics
.png)
Qu Biologics, Inc. is a Canadian biotechnology company based in Burnaby, British Columbia.
¶ History
Qu Biologics was founded in 2007 by Hal Gunn and Rob Freeman.[1]
¶ COVID-19
On December 18, 2020, the National Research Council Canada announced up to $109,764.00 in funding through the Industrial Research Assistance Program (NRC IRAP) to Qu Biologics "for a project to provide proof-of-concept evidence for the safety and efficacy of a preventative treatment as well as therapeutic use of a treatment to protect the lungs and prevent serious COVID-19 infection."[2]
¶ Organization
Qu Biologics is a member organization of the Biotechnology Innovation Organization (BIO) and N2 Canada.[3][4]
¶ Funding
Since 2007, Qu Biologics has “raised over CAD$40 million in funding from private investors and government funding”.[5]
The company has received grants and investment funding from:[6][7]
- Asian Capital Alliance (ACA Group)
- David Lopez[8]
- Harmonix Fund
- Integro Capital[9]
- National Research Council Canada's Industrial Research Assistance Program (NRC IRAP)
¶ Team
| Name | Position | Notes |
|---|---|---|
| Hal Gunn | CEO and Founder[10] | InspireHealth, University of British Columbia (UBC) |
| Simon Sutcliffe | Chief Medical Officer - Oncology | Princess Margaret Hospital |
| Ted Steiner | Chief Medical Officer - Infectious Diseases | University of British Columbia |
| Matt Cahill | Chief Operating Officer | Deep Genomics, University of Toronto |
| Shirin Kalyan | Vice President, Scientific Innovation | Alexander von Humboldt Foundation, University of British Columbia |
| David Mullins | Chief Scientific Officer (former) | Norris Cotton Cancer Center |
| Gillian Vandermeirsch | Vice President of Operations (former) | Pasteur Institute |
| Bob Cory | Vice President of Business Development (former) | Bioasis Technologies, MIGENIX, Illumigen Biosciences |
| Julie Jang | Director of Communications (former) | Sirona Biochem, Zalicus |
| Heidi Biagi | Director of Project Management (former) | Novadeq Technologies, QLT |
| Russell McAllister | Vice President of Finance (former) | Lakewood-Amedex, H.C. Wainwright & Co., Thomas Weisel Partners, Merriman Curhan Ford & Co., PricewaterhouseCoopers |
| Jim Pankovich | Vice President of Clinical Operations & Drug Development (former) | MIGENIX, Inex Pharmaceuticals, CV Technologies |
| Kevin Harper | Acting Director of Manufacturing (former) | HH Consultancy, Sanofi Pasteur, Novartis |
| Nicole Clendinning | Director of Finance (former) | Chartered Professional Accountants of British Columbia |
| Alun Rees | Vice President of Manufacturing (former) | STEMCELL Technologies, QLT, GlaxoSmithKline, Bio Products Laboratories (BPL) |
| Mark Bazett | Director of Preclinical and Translational Research (former) | Meakins-Christie Laboratories |
| Julia Levy | Board member[11] | QLT, Foundation Fighting Blindness, Wilmer Eye Institute, Life Sciences British Columbia, University of British Columbia |
| Karn Manhas | Board member | Terramera, Young Presidents' Organization (YPO), Unreasonable Group |
| Mike Leschuk | Board member | Leschuk-Weisz Developments, Rob Freeman Foundation, PricewaterhouseCoopers, London Telecom Group |
| Foster Coulson | Board member | Integro Capital |
| Marc Lambiotte | Board member | West Coast General Hospital |
| Dieter Kabelitz | Scientific Advisor[12] | University of Kiel, German Society of Immunology, International Union of Immunological Societies, Rockefeller University, University of Heidelberg, Paul Ehrlich Institute |
| Bruce Vallance | Scientific Advisor | Child & Family Research Institute (CFRI), Crohn’s and Colitis Canada, CH.I.L.D. Foundation, British Columbia Children's Hospital, University of British Columbia |
| Balfour Sartor | Scientific Advisor | University of North Carolina at Chapel Hill, Crohn's & Colitis Foundation |
| Michael Noble | Scientific Advisor | University of British Columbia |
| Robert E.W. Hancock | Scientific Advisor | University of British Columbia, MIGENIX, Inimex Pharmaceuticals, ABT Innovations, Sepset Biotherapeutics, Centre for Drug Research and Development (CDRD) |
| Brian Feagan | Clinical Advisor[13] | Schulich School of Medicine & Dentistry, London Health Sciences Centre, Robarts Research Institute |
| William Sandborn | Clinical Advisor | University of California, San Diego, UC San Diego Health System, Mayo Clinic |
| Brian Bressler | Clinical Advisor | University of British Columbia, Massachusetts General Hospital, Harvard Medical School |
| John Marshall | Clinical Advisor | McMaster University, Hamilton Health Sciences |
¶ External links
Our History. Qu Biologics Inc. Retrieved May 1, 2023, from http://archive.today/2023.05.01-205011/https://www.qubiologics.com/who-we-are/our-history/ ↩︎
National Research Council of Canada supports development of 4 COVID-19 therapeutic candidates. (2020, December 18). Government of Canada. http://archive.today/2023.09.06-231214/https://www.canada.ca/en/national-research-council/news/2020/12/national-research-council-of-canada-supports-development-of-4-covid-19-therapeutic-candidates.html ↩︎
BIO Member Directory. Biotechnology Innovation Organization. Retrieved September 30, 2022, from https://web.archive.org/web/20220930103715/https://www.bio.org/bio-member-directory ↩︎
Members. N2 Canada. Retrieved October 11, 2022, from http://archive.today/2022.10.11-054124/https://n2canada.ca/members/ ↩︎
Our History. Qu Biologics Inc. Retrieved May 1, 2023, from http://archive.today/2023.05.01-205011/https://www.qubiologics.com/who-we-are/our-history/ ↩︎
Qu Biologics Inc. - Funding, Financials, Valuation & Investors. Crunchbase. Retrieved May 1, 2023, from https://www.crunchbase.com/organization/qu-biologics-inc/company_financials ↩︎
Portfolio. ACA Group. Retrieved May 1, 2023, from http://archive.today/2023.05.01-212531/https://aca-investments.com/portfolio/ ↩︎
Experience | Dave Lopez. LinkedIn. Retrieved July 19, 2023, from http://archive.today/2023.07.19-225940/https://www.linkedin.com/in/dave-lopez-7b2306193/details/experience/ ↩︎
Home. Integro Capital. Retrieved July 19, 2023, from http://archive.today/2023.07.19-230516/https://integrocap.com/ ↩︎
Management Team. Qu Biologics Inc. Retrieved May 2, 2023, from https://web.archive.org/web/20230502003205/https://www.qubiologics.com/who-we-are/management-team/ ↩︎
Board of Directors. Qu Biologics Inc. Retrieved May 2, 2023, from https://web.archive.org/web/20230502044842/https://www.qubiologics.com/who-we-are/board-of-directors/ ↩︎
Scientific Advisory Board. Qu Biologics Inc. Retrieved May 7, 2023, from https://web.archive.org/web/20230507165939/https://www.qubiologics.com/who-we-are/scientific-advisory-board/ ↩︎
IBD Clinical Advisors. Qu Biologics Inc. Retrieved May 7, 2023, from https://web.archive.org/web/20230507171856/https://www.qubiologics.com/who-we-are/clinical-advisors/ ↩︎